Quick Answer
Beam Therapeutics Inc. reported Common Stock Shares Outstanding of 101.75 million shares for the year ending 2025.
- Beam Therapeutics Inc. showed an increase of +21.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Beam Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: 49.08 million shares | Q2 2020: 49.65 million shares | Q3 2020: 50.44 million shares | Q1 2021: 61.74 million shares | Q2 2021: 64.45 million shares | Q3 2021: 67.73 million shares | Q1 2022: 69.75 million shares | Q2 2022: 70.31 million shares | Q3 2022: 70.46 million shares | Q1 2023: 74.44 million shares | Q2 2023: 77.95 million shares | Q3 2023: 79.38 million shares | Q1 2024: 82.28 million shares | Q2 2024: 82.39 million shares | Q3 2024: 82.56 million shares | Q1 2025: 100.56 million shares | Q2 2025: 100.76 million shares | Q3 2025: 101.36 million shares.
- Over the full 7 years of available data (2019 to 2025), Beam Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 1,288.8%.
- Historical annual values: Fiscal year 2025: 101.75 million shares | Fiscal year 2024: 83.63 million shares | Fiscal year 2023: 81.63 million shares | Fiscal year 2022: 71.28 million shares | Fiscal year 2021: 68.39 million shares | Fiscal year 2020: 57.25 million shares | Fiscal year 2019: 7.33 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: